Report Detail
Global Artificial Intelligence Pathology Diagnosis Market 2022 by Company, Regions, Type and Application, Forecast to 2028
- RnM4484125 |
- 18 August, 2022 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Other
The Artificial Intelligence Pathology Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Artificial Intelligence Pathology Diagnosis market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Artificial Intelligence Pathology Diagnosis market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the Artificial Intelligence Pathology Diagnosis global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Histopathology segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Artificial Intelligence Pathology Diagnosis include Aiforia, AIRA Matrix, Deep Bio, DoMore Diagnostics and Indica Labs, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Artificial Intelligence Pathology Diagnosis market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Artificial Intelligence Pathology Diagnosis companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Artificial Intelligence Pathology Diagnosis market based on the following parameters – headquarters, products portfolio, Artificial Intelligence Pathology Diagnosis revenue, and gross margin, recent developments.
Evaluation and forecast the Artificial Intelligence Pathology Diagnosis market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Artificial Intelligence Pathology Diagnosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Market segment by Application (2017-2028; USD Million)
Hospital
Diagnostic Laboratory
Training and Education
The key market players for global Artificial Intelligence Pathology Diagnosis market are listed below:
Aiforia
AIRA Matrix
Deep Bio
DoMore Diagnostics
Indica Labs
Mindpeak
Paige AI
Path AI
Tempus
Verily
Aignostics GmbH
Gestalt Diagnostics
Primma
Region Segment (2017-2028; USD Million)
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Artificial Intelligence Pathology Diagnosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Artificial Intelligence Pathology Diagnosis, with revenue, gross margin and global market share of Artificial Intelligence Pathology Diagnosis from 2019 to 2022.
Chapter 3, the Artificial Intelligence Pathology Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Intelligence Pathology Diagnosis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Artificial Intelligence Pathology Diagnosis research findings and conclusion, appendix and data source.
1 Market Overview
- 1.1 Product Overview and Scope of Artificial Intelligence Pathology Diagnosis
- 1.2 Classification of Artificial Intelligence Pathology Diagnosis by Type
- 1.2.1 Overview: Global Artificial Intelligence Pathology Diagnosis Market Size by Type: 2017 Versus 2021 Versus 2028
- 1.2.2 Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Type in 2021
- 1.2.3 Histopathology
- 1.2.4 Cytopathology
- 1.2.5 Immunohistochemical Pathology
- 1.2.6 Molecular Pathology
- 1.3 Global Artificial Intelligence Pathology Diagnosis Market by Application
- 1.3.1 Overview: Global Artificial Intelligence Pathology Diagnosis Market Size by Application: 2017 Versus 2021 Versus 2028
- 1.3.2 Hospital
- 1.3.3 Diagnostic Laboratory
- 1.3.4 Training and Education
- 1.4 Global Artificial Intelligence Pathology Diagnosis Market Size & Forecast
- 1.5 Global Artificial Intelligence Pathology Diagnosis Market Size and Forecast by Region
- 1.5.1 Global Artificial Intelligence Pathology Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
- 1.5.2 Global Artificial Intelligence Pathology Diagnosis Market Size by Region, (2017-2022)
- 1.5.3 North America Artificial Intelligence Pathology Diagnosis Market Size and Prospect (2017-2028)
- 1.5.4 Europe Artificial Intelligence Pathology Diagnosis Market Size and Prospect (2017-2028)
- 1.5.5 Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size and Prospect (2017-2028)
- 1.5.6 South America Artificial Intelligence Pathology Diagnosis Market Size and Prospect (2017-2028)
- 1.5.7 Middle East and Africa Artificial Intelligence Pathology Diagnosis Market Size and Prospect (2017-2028)
- 1.6 Market Drivers, Restraints and Trends
- 1.6.1 Artificial Intelligence Pathology Diagnosis Market Drivers
- 1.6.2 Artificial Intelligence Pathology Diagnosis Market Restraints
- 1.6.3 Artificial Intelligence Pathology Diagnosis Trends Analysis
2 Company Profiles
- 2.1 Aiforia
- 2.1.1 Aiforia Details
- 2.1.2 Aiforia Major Business
- 2.1.3 Aiforia Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.1.4 Aiforia Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.1.5 Aiforia Recent Developments and Future Plans
- 2.2 AIRA Matrix
- 2.2.1 AIRA Matrix Details
- 2.2.2 AIRA Matrix Major Business
- 2.2.3 AIRA Matrix Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.2.4 AIRA Matrix Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.2.5 AIRA Matrix Recent Developments and Future Plans
- 2.3 Deep Bio
- 2.3.1 Deep Bio Details
- 2.3.2 Deep Bio Major Business
- 2.3.3 Deep Bio Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.3.4 Deep Bio Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.3.5 Deep Bio Recent Developments and Future Plans
- 2.4 DoMore Diagnostics
- 2.4.1 DoMore Diagnostics Details
- 2.4.2 DoMore Diagnostics Major Business
- 2.4.3 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.4.4 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.4.5 DoMore Diagnostics Recent Developments and Future Plans
- 2.5 Indica Labs
- 2.5.1 Indica Labs Details
- 2.5.2 Indica Labs Major Business
- 2.5.3 Indica Labs Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.5.4 Indica Labs Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.5.5 Indica Labs Recent Developments and Future Plans
- 2.6 Mindpeak
- 2.6.1 Mindpeak Details
- 2.6.2 Mindpeak Major Business
- 2.6.3 Mindpeak Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.6.4 Mindpeak Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.6.5 Mindpeak Recent Developments and Future Plans
- 2.7 Paige AI
- 2.7.1 Paige AI Details
- 2.7.2 Paige AI Major Business
- 2.7.3 Paige AI Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.7.4 Paige AI Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.7.5 Paige AI Recent Developments and Future Plans
- 2.8 Path AI
- 2.8.1 Path AI Details
- 2.8.2 Path AI Major Business
- 2.8.3 Path AI Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.8.4 Path AI Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.8.5 Path AI Recent Developments and Future Plans
- 2.9 Tempus
- 2.9.1 Tempus Details
- 2.9.2 Tempus Major Business
- 2.9.3 Tempus Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.9.4 Tempus Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.9.5 Tempus Recent Developments and Future Plans
- 2.10 Verily
- 2.10.1 Verily Details
- 2.10.2 Verily Major Business
- 2.10.3 Verily Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.10.4 Verily Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.10.5 Verily Recent Developments and Future Plans
- 2.11 Aignostics GmbH
- 2.11.1 Aignostics GmbH Details
- 2.11.2 Aignostics GmbH Major Business
- 2.11.3 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.11.4 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.11.5 Aignostics GmbH Recent Developments and Future Plans
- 2.12 Gestalt Diagnostics
- 2.12.1 Gestalt Diagnostics Details
- 2.12.2 Gestalt Diagnostics Major Business
- 2.12.3 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.12.4 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.12.5 Gestalt Diagnostics Recent Developments and Future Plans
- 2.13 Primma
- 2.13.1 Primma Details
- 2.13.2 Primma Major Business
- 2.13.3 Primma Artificial Intelligence Pathology Diagnosis Product and Solutions
- 2.13.4 Primma Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.13.5 Primma Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Artificial Intelligence Pathology Diagnosis Revenue and Share by Players (2019, 2020, 2021, and 2022)
- 3.2 Market Concentration Rate
- 3.2.1 Top 3 Artificial Intelligence Pathology Diagnosis Players Market Share in 2021
- 3.2.2 Top 10 Artificial Intelligence Pathology Diagnosis Players Market Share in 2021
- 3.2.3 Market Competition Trend
- 3.3 Artificial Intelligence Pathology Diagnosis Players Head Office, Products and Services Provided
- 3.4 Artificial Intelligence Pathology Diagnosis Mergers & Acquisitions
- 3.5 Artificial Intelligence Pathology Diagnosis New Entrants and Expansion Plans
4 Market Size Segment by Type
- 4.1 Global Artificial Intelligence Pathology Diagnosis Revenue and Market Share by Type (2017-2022)
- 4.2 Global Artificial Intelligence Pathology Diagnosis Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
- 5.1 Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Application (2017-2022)
- 5.2 Global Artificial Intelligence Pathology Diagnosis Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
- 6.1 North America Artificial Intelligence Pathology Diagnosis Revenue by Type (2017-2028)
- 6.2 North America Artificial Intelligence Pathology Diagnosis Revenue by Application (2017-2028)
- 6.3 North America Artificial Intelligence Pathology Diagnosis Market Size by Country
- 6.3.1 North America Artificial Intelligence Pathology Diagnosis Revenue by Country (2017-2028)
- 6.3.2 United States Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 6.3.3 Canada Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 6.3.4 Mexico Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
- 7.1 Europe Artificial Intelligence Pathology Diagnosis Revenue by Type (2017-2028)
- 7.2 Europe Artificial Intelligence Pathology Diagnosis Revenue by Application (2017-2028)
- 7.3 Europe Artificial Intelligence Pathology Diagnosis Market Size by Country
- 7.3.1 Europe Artificial Intelligence Pathology Diagnosis Revenue by Country (2017-2028)
- 7.3.2 Germany Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 7.3.3 France Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 7.3.4 United Kingdom Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 7.3.5 Russia Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 7.3.6 Italy Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
- 8.1 Asia-Pacific Artificial Intelligence Pathology Diagnosis Revenue by Type (2017-2028)
- 8.2 Asia-Pacific Artificial Intelligence Pathology Diagnosis Revenue by Application (2017-2028)
- 8.3 Asia-Pacific Artificial Intelligence Pathology Diagnosis Market Size by Region
- 8.3.1 Asia-Pacific Artificial Intelligence Pathology Diagnosis Revenue by Region (2017-2028)
- 8.3.2 China Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 8.3.3 Japan Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 8.3.4 South Korea Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 8.3.5 India Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 8.3.6 Southeast Asia Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 8.3.7 Australia Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
- 9.1 South America Artificial Intelligence Pathology Diagnosis Revenue by Type (2017-2028)
- 9.2 South America Artificial Intelligence Pathology Diagnosis Revenue by Application (2017-2028)
- 9.3 South America Artificial Intelligence Pathology Diagnosis Market Size by Country
- 9.3.1 South America Artificial Intelligence Pathology Diagnosis Revenue by Country (2017-2028)
- 9.3.2 Brazil Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 9.3.3 Argentina Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
- 10.1 Middle East & Africa Artificial Intelligence Pathology Diagnosis Revenue by Type (2017-2028)
- 10.2 Middle East & Africa Artificial Intelligence Pathology Diagnosis Revenue by Application (2017-2028)
- 10.3 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Country
- 10.3.1 Middle East & Africa Artificial Intelligence Pathology Diagnosis Revenue by Country (2017-2028)
- 10.3.2 Turkey Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 10.3.3 Saudi Arabia Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
- 10.3.4 UAE Artificial Intelligence Pathology Diagnosis Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
- 12.1 Methodology
- 12.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Artificial Intelligence Pathology Diagnosis. Industry analysis & Market Report on Artificial Intelligence Pathology Diagnosis is a syndicated market report, published as Global Artificial Intelligence Pathology Diagnosis Market 2022 by Company, Regions, Type and Application, Forecast to 2028. It is complete Research Study and Industry Analysis of Artificial Intelligence Pathology Diagnosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
